Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation

Clin Transplant. 2016 Mar;30(3):247-55. doi: 10.1111/ctr.12683. Epub 2016 Feb 11.

Abstract

Background: Frailty in non-transplant populations increases morbidity and mortality. Muscle wasting is an important frailty characteristic. Low body mass index is used to measure wasting, but can over- or underestimate muscle mass. Computed tomography (CT) software can directly measure muscle mass. It is unknown if muscle wasting is important in lung transplantation.

Aim and methods: The aim of this single-center, retrospective cohort study was to determine whether pre-transplant low muscle mass (as measured by CT using Slice-O-matic software at L2-L3 interspace) was associated with post-transplantation mortality, hospital and intensive care unit length of stay (LOS), duration of mechanical ventilation, or primary graft dysfunction. Lung transplant recipients from 2000 to 2012 with a CT scan less than six months prior to transplant were included. Univariate, multivariate, and Kaplan-Meier analyses were conducted.

Results: Thirty-six patients were included. Those with low muscle index (lower 25th percentile) had a worse survival (hazard ratio = 3.83; 95% confidence interval 1.42-10.3; p = 0.007) and longer hospital LOS by an estimated 7.2 d (p = 0.01) when adjusted for age and sex as compared to those with higher muscle index.

Conclusion: Low muscle index at lung transplantation is associated with worse survival and increased hospital LOS.

Keywords: body composition; frailty; lung transplantation; mortality; muscle wasting.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Follow-Up Studies
  • Graft Rejection / diagnosis*
  • Graft Rejection / diagnostic imaging
  • Graft Rejection / etiology
  • Graft Survival
  • Humans
  • Lung Diseases / surgery*
  • Lung Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Muscular Atrophy / diagnostic imaging
  • Muscular Atrophy / physiopathology*
  • Postoperative Complications*
  • Primary Graft Dysfunction / diagnosis*
  • Primary Graft Dysfunction / diagnostic imaging
  • Primary Graft Dysfunction / etiology
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Tomography, X-Ray Computed / methods